Sunshield Chemicals Ltd

Sunshield Chemicals Ltd – Trading Window closed from 01 October 2026 until 48 hours after the declaration of unaudited results for the quarter and half-year ended 30 September 2026

Target Company

• Sunshield Chemicals Limited.

Disclosing Party (Promoter Group)

• Acquirer: Swarna Malhotra; PACs: Indus Petrochem, Coppersmith Energies, Sudhir Malhotra, Jeet Malhotra.
• Promoter group status: Yes.

Transaction Type

• Acquisition of voting rights.

Pre-Transaction Holding

• Total voting rights before: 5,853,675.
• Promoter group pre-holdings: Swarna Malhotra 88,867; Indus Petrochem 5,484,493; Coppersmith 277,973; Sudhir Malhotra 837; Jeet Malhotra 1,505.

Transaction Details

• Acquired voting rights: 242.
• Mode: Open Market; Date: 2 September 2026.

Post-Transaction Holding

• New totals: Swarna Malhotra 89,109; Indus Petrochem 5,484,493; Coppersmith Energies 277,973; Sudhir Malhotra 837; Jeet Malhotra 1,505.
• Post-holding total voting rights: 5,853,917.
• Post-diluted share capital: Rs 8,79,48,360.
• Post-holding percentage: 66.56% of diluted capital.

Capital Context

• Equity share capital before/after: Rs 8,79,48,360.
• Total diluted capital after: Rs 8,79,48,360.

Transaction summary

• Target: Sunshield Chemicals Limited.
• Disclosing party: Swarna Malhotra; promoter group.
• PACs: Indus Petrochem Ltd; Coppersmith Energies & Project Pvt Ltd; Sudhir Malhotra; Jeet Malhotra.
• Transaction type: Acquisition of voting rights.
• Date of acquisition: 31 August 2026.
• Mode: Open Market.
• Pre-transaction VR: Swarna 0.99%; Indus 62.36%; Coppersmith 3.16%; Sudhir 0.01%; Jeet 0.02%.
• Acquired: 1,443 voting rights (VRs) at 0.02%.
• Post-transaction Swarna: 88,867 shares (1.01%).
• Post-transaction Indus Petrochem: 54,84,493 shares (62.36%).
• Post-transaction Coppersmith Energies: 2,77,973 shares (3.16%).
• Post-transaction Sudhir Malhotra: 837 shares (0.01%).
• Post-transaction Jeet Malhotra: 1,505 shares (0.02%).
• Equity share capital before: Rs 8,79,48,360.
• Equity share capital after: Rs 8,79,48,360.
• Total diluted share capital after: Rs 8,79,48,360.

Financial results and audit

• Approved unaudited quarterly results for quarter ended 30 June 2026.
• Limited Review Reports attached; auditors issued an unmodified report.
• Trading window opens 48 hours after declaration of results.

Meeting Details

• Board meeting on 11 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and take on record unaudited quarterly financial results for the quarter ended 30 June 2026.

Other Notes

• Trading window closed for designated persons and their immediate relatives till 13 August 2026.

Independent director reappointment

• Reason: Reappointment of Cyrus Poonevala as Independent Director.
• Date and term: Effective 15 January 2027 for five years.
• Profile and disclosures: 30+ years in aviation; not related to directors; not debarred.

AGM details

• AGM held on 3 July 2026 via VC/OVAM.
• Meeting ran from 11:00 AM to 11:57 AM.
• Record date: 26 June 2026.
• Total shareholders on record: 5,434.

Resolutions and outcomes

• Resolution 1: Adopt Audited Financial Statements for year ended 31 March 2026; Passed.
• Resolution 2: Declare final dividend on equity shares; Passed.
• Resolution 3: Re-appointment of Dr. Anand Parihar, retiring by rotation; Passed.
• Resolution 4: Ratification of remuneration to Cost Auditor for FY 2026-27; Passed.
• Resolution 5: Re-appointment of Cyrus Poonevala as Independent Director for second five-year term (2027–2032); Special; Passed.

Appointments and remuneration

• Dr. Anand Parihar re-appointed as Director, retiring by rotation.
• Cyrus Poonevala re-appointed as Independent Director for 2027–2032 term.
• Remuneration of Cost Auditor Kishore Bhatia & Associates ratified for FY 2026-27.

AGM Details

• Date and time: 3 July 2026, 11:00 IST
• Mode: VC/OAVM
• Quorum counted via VC/OAVM

Resolutions

• Adoption of financial statements and reports — Ordinary
• Dividend approved for FY ended 31 March 2026 — Ordinary
• Re-appointment of retiring director Dr. Anand Parihar — Ordinary
• Remuneration ratification for Cost Auditors for FY2027 — Ordinary
• Reappointment of Cyrus Poonevala as Independent Director — Special

Voting Results

• Poll results to be disclosed to stock exchange within two working days

Director Changes

• Dr. Anand Parihar re-appointed as Director
• Cyrus Poonevala re-appointed as Independent Director

Auditor Appointments

• Cost Auditor remuneration ratified for FY2027